IP Library Granted Patent US 7,998,960
Granted Patent B2
US 7,998,960 · App. 11/913,514 · Granted Aug 16, 2011

Affinity adsorbents for plasminogen

Assignee: Prometic Biosciences Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,998,960
App. No.
11/913,514
Granted
Aug 16, 2011
Kind
B2
Abstract

For the separation, removal, isolation, purification, characterization, identification or quantification of plasminogen or a protein that is a plasminogen analogue, an affinity adsorbent is used that is a compound of formula (II) wherein one X is N and the other is N, C—Cl or C—CN; A is a support matrix, optionally linked to the triazine ring by a spacer; Z is O, S or N—R and R is H, C 1-6 alkyl, C 1-6 hydroxyalkyl, benzyl or &bgr;-phenylethyl; B is an optionally substituted hydrocarbon linkage containing from 1 to 10 carbon atoms; D is H, OH or a primary amino, secondary amino, tertiary amino, quaternary ammonium, imidazole, guanidino or amidino group; or B-D is —CHCOOH—(CH 2 ) 3-4 —NH 2 ; and q is 2 to 6.

Claims (20)

1. A method for purifying plasminogen or a protein that is a plasminogen analogue, wherein said method comprises contacting a sample containing plasminogen or a plasminogen analogue with an affinity adsorbent of formula II

wherein one X is N and the other X is N, C—Cl or C—CN;

A is a support matrix, optionally linked to the triazine ring by a spacer;

Z is O, S or N—R and R is H, C 1-6 alkyl, C 1-6 hydroxyalkyl, benzyl or β-phenylethyl;

B is an optionally substituted hydrocarbon linkage containing from 1 to 10 carbon atoms;

D is OH or a primary amino; and

q is 2 to 6;

whereby plasminogen or a plasminogen analogue present in the sample binds to the affinity adsorbent of formula II and wherein said method further comprises removing the plasminogen, or analogue thereof, from the affinity adsorbent to obtain plasminogen, or analogue thereof, of greater than 85% purity.

2. The method, according to claim 1 , wherein the adsorbent is of formula III:

3. The method, according to claim 1 , wherein the adsorbent is of formula V:

4. The method, according to claim 1 , wherein the plasminogen is in a sample of plasma.

5. The method, according to claim 1 , wherein said affinity adsorbent is a compound of formula II

wherein one X is N and the other X is N, C—Cl or C—CN;

A is a support matrix, optionally linked to the triazine ring by a spacer;

Z is NH;

B is a hydrocarbon linkage containing from 1 to 10 carbon atoms;

D is OH; and

q is 2 to 6.

6. The method, according to claim 1 , wherein the affinity adsorbent is contacted with a sample of plasma.

7. The method, according to claim 1 , wherein the adsorbent is of formula. IV:

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2021
From: PROMETIC BIOSEPARATIONS LTD
To: PROMETIC BIOTHERAPEUTICS INC.
Reel/Frame 057801/0573 →
CHANGE OF NAME Recorded Oct 13, 2021
From: PROMETIC BIOSCIENCES LTD
To: PROMETIC BIOSEPARATIONS LTD
Reel/Frame 057788/0451 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2008
From: BETLEY, JASON RICHARD; PEARSON, JAMES CHRISTOPHER; KUHN, CLAUDIA HILDEGARD; BAINES, BALDEV SINGH
To: PROMETIC BIOSCIENCES LTD.
Reel/Frame 021348/0391 →
Priority Claims (1)
GB 0509438.8 · May 9, 2005 · national
Continuity (1)
Related Publication 20080293925A1 · Nov 27, 2008